Bristol-Myers Squibb Company
Why it moved today
BMY rose 2.10% as analysts highlighted growth sustainability in the cardiovascular franchise, driving strong investor buying throughout the session.
BMY Price Trend
Data source: Yahoo Finance
High
$63.68
Low
$61.42
Change
+2.47%
Cardiovascular franchise growth potential
For informational purposes only. Not investment advice.
A factual summary of how strongly today's price move is backed by trend, momentum, volume, and news - not a rating of the stock, a buy or sell signal, or a forecast. A sharp fall can score as high as a sharp rise. See the methodology.
5 free analyses remaining
Create a free account to track BMY and get unlimited analyses.
Bristol-Myers Squibb Company (BMY) gained 1.78% today, trading at $63.43 on the NYSE/NASDAQ. BMY rose 2.10% as analysts highlighted growth sustainability in the cardiovascular franchise, driving strong investor buying throughout the session. Key support sits at $61.42 with resistance near $63.57.
Cardiovascular franchise growth potential
Positive sentiment regarding cardiovascular franchise expansion spurred robust buying demand, propelling the equity higher despite broader market weakness.
MACD Bullish
Headlines we considered when writing this analysis. Click through to verify against the original publisher.
Look up any ticker or company to see today's story.
